ERIS Lifesciences Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 501.48 | 470.37 | 304.28 |
| Operating Expense | 335.03 | 324.09 | 255.53 |
| Net Profit | 129.15 | 48.30 | -8.60 |
| Net Profit Margin | 25.75% | 10.27% | -2.83% |
| Earning Per Share | 9.32 | 3.49 | -0.63 |
| EBIDTA | 225.94 | 140.67 | 65.29 |
| Effective Tax Rate | 8.32% | 6.99% | -15.65% |
Particulars
Sep 2026
Revenue501.48
Operating Expense335.03
Net Profit129.15
Net Profit Margin25.75
Earning Per Share9.32
EBIDTA225.94
Effective Tax Rate8.32
